DMAC
DiaMedica Therapeutics Inc
8.40$
+2.3%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +0.0% | +25.0% | +0.0% | +10.0% | +0.0% | -72.7% | +500.0% | +11.1% | -45.0% | +9.1% | – | |
| – | +7.3% | +7.0% | -9.2% | +27.5% | +4.2% | +47.2% | -11.1% | +31.8% | +17.3% | -31.0% | +36.0% | – | |
| – | – | -236.7% | – | +252.3% | -25.3% | -106.7% | – | – | -99.8% | +9,733.3% | +253.2% | – | |
| – | -70.0% | +200.0% | -99.2% | +13,061.7% | -22.2% | +71.4% | -50.0% | +169.8% | -62.9% | +33.3% | -62.5% | – | |
| – | +412.0% | -31.3% | +12.5% | -217.9% | – | +27.2% | +35.3% | -392.6% | – | -126.4% | – | – | |
| – | +10,249,900.0% | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | +0.0% | +0.0% | -33.3% | +50.0% | -33.3% | +50.0% | +0.0% | – | |
| – | -83.3% | +0.0% | – | -99.0% | -2.4% | -24.2% | +76.9% | +19,783.3% | -62.2% | -96.6% | -68.3% | – | |
| – | – | -205.8% | – | -183.0% | – | – | – | -151.5% | – | -187.5% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.